Document and Entity Information Document Information [Table] Document Information [Line Items] Document Type Document Quarterly Report Document Period End Date Document Transition Report Securities Act File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag BALANCE SHEETS Statement [Table] Statement [Line Items] Statement Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Grants Receivable, Current Grant receivables Prepaid Expense, Current Prepaid expenses and other current assets Restricted Cash Equivalents, Current Restricted cash equivalents Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Operating Lease, Right-of-Use Asset Right-of-use assets, operating leases Total operating lease assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Liabilities, Current [Abstract] Current liabilities: Current Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Total The amount of current portion of deferred grant income as at the end of the reporting period. Deferred Grant Income, Current Deferred grant income, current Operating Lease, Liability, Current Operating lease liabilities, current Other Liabilities, Current Other current liabilities Liabilities, Current Total current liabilities Operating Lease, Liability, Noncurrent Operating lease liabilities, non-current Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies (Note 6) Equity, Attributable to Parent [Abstract] Stockholders' equity: Preferred Stock, Value, Issued Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025 Common Stock, Value, Issued Common stock, $0.001 par value, 250,000,000 shares authorized; 95,055,773 and 88,904,161 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Equity, Attributable to Parent Ending Balances Beginning Balances Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Operating Income (Loss) [Abstract] Operating Expenses: Research and Development Expense Research and development General and Administrative Expense General and administrative General and administrative expenses Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Other Nonoperating Income (Expense) [Abstract] Other income (expense): Amount of income related to grants. Grant Income Grant income Grant income Other Noncash Income (Expense) Other income, net Interest Income (Expense), Nonoperating Interest expense Other Nonoperating Income (Expense) Total other income, net Comprehensive Income (Loss), Net of Tax, Attributable to Parent Net loss and comprehensive loss Net Loss per Share Net loss per share: Earnings Per Share, Basic Net loss per share, basic (in dollars per share) Earnings Per Share, Diluted Net loss per share, diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted-average common shares outstanding: Weighted Average Number of Shares Outstanding, Basic Weighted-average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted-average common shares outstanding, diluted (in shares) STATEMENTS OF STOCKHOLDERS' EQUITY Sale of Stock [Axis] Sale of Stock [Domain] Represents information pertaining to at the market offering. At Market Offering [Member] At The Market Offering 2022 ATM Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated Deficit Increase (Decrease) in Stockholders' Equity [Roll Forward] Shareholders' Equity Shares, Outstanding Ending Balances (in shares) Beginning Balances (in shares) Stock Issued During Period, Value, New Issues Issuance of common stock under the 2022 ATM, net of commissions and allocated fees Stock Issued During Period, Shares, New Issues Shares issued (in shares) Issuance of common stock under the 2022 ATM, net of commissions and allocated fees (in shares) Stock Issued During Period, Value, Stock Options Exercised Exercise of common stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Options exercised (in shares) Exercise of common stock options (in shares) Aggregate value of stock related to vesting of Restricted Stock Units during the period. Stock Issued During Period, Value, Vesting of Restricted Stock Units Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes Total number of shares issued during the period, including shares forfeited, as a result of vesting of Restricted Stock Units. Stock Issued During Period, Shares, Vesting of Restricted Stock Units Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes (in shares) APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Equity-based compensation Net loss Net loss Net loss STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets, net of adjustments. Depreciation, Depletion and Amortization, Net of Adjustments Depreciation and amortization Share-Based Payment Arrangement, Noncash Expense Equity-based compensation Operating Lease, Right-of-Use Asset, Periodic Reduction Amortization of right-of-use assets Amount of gain recognized on lease modification. Gain on Lease Modification Gain on lease modification Gain (Loss) on Disposition of Property Plant Equipment Loss on disposal of property and equipment Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Amount of increase and decrease in grant receivables. Increase (Decrease) In Grant Receivables Grant receivables Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Amount of increase (decrease) in current deferred grant income. Increase (Decrease) In Deferred Grant Income, Current Deferred grant income and other liabilities Increase (Decrease) in Operating Lease Liability Operating lease liabilities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment Payments for property and equipment Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Proceeds from Issuance of Common Stock Proceeds from issuance of common stock under the ATM sales agreements, net of commissions and allocated fees Proceeds from Stock Options Exercised Proceeds from the exercise of common stock options Payment, Tax Withholding, Share-Based Payment Arrangement Payment of employee withholding taxes on vested restricted stock units Repayments of Short-Term Debt Payments on loan payable Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net decrease in cash, cash equivalents and restricted cash equivalents Cash and Cash Equivalents [Abstract] Cash, cash equivalents, and restricted cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash, cash equivalents, and restricted cash equivalents - end of period Cash, cash equivalents, and restricted cash equivalents - beginning of period Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosures of non-cash financing activities: Amount of remeasurement of right-of-use asset and operating lease liability. Remeasurement of Right-of-use Asset and Operating Lease Liability Operating lease assets and liabilities recognized during the period Description of Business and Financial Condition Business Description and Basis of Presentation [Text Block] Description of Business and Financial Condition Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Financial Instruments and Fair Value Measurements Fair Value Disclosures [Text Block] Financial Instruments and Fair Value Measurements Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses Other Current Liabilities. Entire disclosure of other current liabilities. Other Current Liabilities [Text Block] Other Current Liabilities Commitments and Contingencies. Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Stockholders' Equity. Equity [Text Block] Stockholders' Equity Equity-based Compensation Share-Based Payment Arrangement [Text Block] Equity-based Compensation Earnings Per Share [Text Block] Net Loss per Share Segment Reporting Segment Reporting Disclosure [Text Block] Segment Reporting Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash, Cash Equivalents, and Restricted Cash Equivalents Receivable [Policy Text Block] Grant Receivables Disclosure of accounting policy for grant income. Grant Income, Policy [Policy Text Block] Grant Income Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Share-Based Payment Arrangement [Policy Text Block] Equity-based Compensation Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Disclosure of accounting policy for warrant accounting. Warrant Accounting Policy [Policy Text Block] Warrant Accounting Earnings Per Share, Policy [Policy Text Block] Net Loss Per Share Segment Reporting, Policy [Policy Text Block] Segments Disclosure of accounting policy for emerging growth company status. Emerging Growth Company [Policy Text Block] Emerging Growth Company Status New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Income Tax, Policy [Policy Text Block] Income Taxes Schedule of Cash and Cash Equivalents [Table Text Block] Schedule of reconciliation of cash, cash equivalents, and restricted cash equivalents Fair Value, by Balance Sheet Grouping [Table Text Block] Summary of financial assets and liabilities measured at fair value Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses Lease, Cost [Table Text Block] Schedule of lease cost Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of maturities of the operating lease liabilities and minimum lease payments Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Summary of outstanding common stock warrants Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of activity for options Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of restricted stock units award activity Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of total equity-based compensation expense Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of outstanding potentially dilutive common stock Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of segment significant expense categories Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Counterparty Name [Axis] Counterparty Name [Domain] Represents information pertaining to Cantor Fitzgerald And Co and B Riley Securities Inc. Cantor Fitzgerald And Co And B Riley Securities Inc [Member] Cantor Fitzgerald & Co. and B. Riley Securities, Inc. Represents information pertaining to Lincoln Park Capital Fund, LLC. Lincoln Park Capital Fund LLC [Member] Lincoln Park AT The Market Offering 2025 [Member] AT The Market Offering 2025 [Member] AT The Market Offering 2025 2025 ATM Represents information relating to equity line financing. Equity Line Financing [Member] Equity Line Financing Represents information pertaining to Registered Direct offerings. Registered Direct Offering [Member] Registered Direct Offerings Subsidiary, Sale of Stock [Line Items] Description of Business and Financial Condition The maximum amount of aggregate offering price. Maximum Aggregate Offering Price Aggregate offering price Maximum equity impact of the value of new stock to be issued under an agreement. Maximum Value Of Stock To Be Issued Under Agreement Maximum value of stock to be issued under agreement The remaining value of stock to be issued under shares offering agreement. Shares Offering Agreement, Remaining Value of Stock to be Issued Remaining common stock available for sale The term of purchase agreement in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Purchase Agreement, Term Term of agreement Represent the information pertaining to number of institutional investors. Number Of Institutional Investors Number of institutional investors Gross proceeds received on stock transaction before deduction of issuance costs. Sale Of Stock, Gross Consideration Received Gross proceeds on sale of stock Shares Issued, Price Per Share Price per share Sale of Stock, Consideration Received on Transaction Consideration received on transaction Payments of Stock Issuance Costs Payment of stock issuance cost Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Summary of Significant Accounting Policies Amount of allowance for credit loss on grants receivable, classified as current. Allowance for Credit Loss, Grants Receivable, Current Allowance for doubtful accounts on grants receivable Unrecognized Tax Benefits Unrecognized income tax Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Expected dividend yield Number of Operating Segments Number of operating segments Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Cash, Cash Equivalents, and Restricted Cash Equivalents Fair Value, by Balance Sheet Grouping [Table] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Money Market Funds [Member] Money market funds Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Quoted Priced in Active Markets (Level 1) Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Financial Instruments and Fair Value Measurements Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] Assets: Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Assets, Fair Value Disclosure Total assets Employee-related Liabilities, Current Employee compensation, benefits, and related accruals Represents accrued research and development expenses. Accrued Research And Development Expenses Research and development costs Accrued Professional Fees, Current Professional fees and other accruals Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument, Name [Domain] Represents information relating to insurance premium financing agreement 3. Insurance Premium Financing Agreement 3 [Member] Insurance Premium Financing Agreement 3 Statement of Financial Position Location, Balance [Axis] Statement of Financial Position Location, Balance [Domain] Other Current Liabilities [Member] Other Current Liabilities Debt Instrument [Line Items] Other Current Liabilities Debt Instrument, Face Amount Face amount Debt Instrument, Interest Rate, Stated Percentage Interest rate (as a percent) Debt Instrument, Periodic Payment Periodic payment Short-Term Debt Short-term loan Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] The amount of operating lease assets as at the end of the reporting period. Operating Lease Assets Operating lease assets Liabilities [Abstract] Liabilities Liabilities, Noncurrent [Abstract] Noncurrent Operating Lease, Liability Total operating lease liabilities Operating Lease, Expense Operating lease costs Loss Contingencies [Table] Loss Contingencies [Line Items] Commitments and Contingencies Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Maturities of the operating lease liabilities and minimum lease payments Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year 2026 (remaining) Lessee, Operating Lease, Liability, to be Paid, Year One 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three 2029 Lessee, Operating Lease, Liability, to be Paid, Year Four 2030 Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Lessee, Operating Lease, Liability, To Be Paid, After Year Four Thereafter Lessee, Operating Lease, Liability, to be Paid Total undiscounted lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: Imputed interest Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease term (years) Operating Lease, Weighted Average Discount Rate, Percent Weighted-average discount rate Operating Lease, Payments Operating cash flows used for operating leases Stock, Class of Stock [Table] Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input, Price Volatility [Member] Volatility Measurement Input, Risk Free Interest Rate [Member] Risk free interest rate Measurement Input, Expected Term [Member] Expected term (in years) Measurement Input, Expected Dividend Rate [Member] Dividend Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represent the information pertains to Registered Direct offerings. Placement Agent Warrants [Member] Placement Agent Warrants Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum Class of Stock [Line Items] Stockholders' Equity Dividends, Common Stock Dividend declared The gross cash inflow associated with the amount received from entity's first offering of stock to the public. Proceeds from Issuance Initial Public Offering, Gross Gross proceeds Represent the information pertaining to number of institutional investors. Number Of Institution Investors Number of institution investors Percentage of fee agreed upon by the entity to pay to agent under the offering. Placement Agent Fees As Percentage Of Gross Proceeds Placement agent fees as percentage of gross proceeds Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of warrants Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise Price Warrants and Rights Outstanding, Term Warrant term Warrants and Rights Outstanding Aggregate fair value Warrants and Rights Outstanding, Measurement Input Warrants and rights outstanding, measurement input Class of Warrant or Right, Outstanding Ending Balance, (In shares) Beginning Balance, (In shares) Number of warrant or right issued during the period. Class Of Warrant Or Right Number Of Warrants Issued Issued, (In shares) Number of securities into which the class of warrant or right exercised. Class Of Warrant Or Right Number Of Securities Exercised Exercised, (In shares) Number of securities into which the class of warrant or right expired. Class Of Warrant Or Right Number Of Securities Expired Expired, (In shares) Number of class of warrants or rights exercisable. Class Of Warrant Or Right Number Of Warrants Exercisable Exercisable, (In shares) Per share or per unit weighted average exercise price of warrants or rights outstanding. Class Of Warrants Or Rights, Weighted Average Exercise Price Ending Balance, (USD/Share) Beginning Balance, (USD/Share) Weighted average exercise price per share or per unit of warrants or rights issued. Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Issued Issued, (USD/Share) Weighted average exercise price per share or per unit of warrants or rights exercised. Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Exercised Exercised, (USD/Share) Weighted average exercise price per share or per unit of warrants or rights expired. Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Expired Expired, (USD/Share) Weighted average exercise price per share or per unit of warrants or rights exercisable. Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Exercisable Exercisable, (In USD/Share) Represent the information pertains to weighted average remaining contractual life. Class Of Warrant Or Right Weighted Average Remaining Contractual Life Weighted-Average Remaining Contractual Life (In Years), Balance Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Plan Name [Axis] Plan Name [Domain] .Represents information relating to 2021 Equity Incentive Plan. Equity Incentive Plan 2021 [Member] 2021 Equity Incentive Plan Represents the information pertaining to 2017 Amended and Restated Equity Incentive Plan. Amended And Restated Equity Incentive Plan 2017 [Member] Amended and Restated 2017 Equity Incentive Plan Represents information relating to Employee Stock Purchase Plan. Employee Stock Purchase Plan [Member] ESPP Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Equity-based Compensation Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Number of shares authorized Number of additional common shares reserved for future issuance. Common Stock, Additional Capital Shares Reserved for Future Issuance Additional common stock shares reserved for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Maximum percentage of common shares issued and outstanding Common Stock, Capital Shares Reserved for Future Issuance Common stock shares reserved for issuance Total number of shares underling the Prior Plan awards that are recycled under share-based payment arrangement. Share-based Compensation Arrangement by Share-based Payment Award, Shares Underlying Prior Plan, Recycled Number Number of shares that may be recycled Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Number of additional shares authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Ending Balance (in shares) Beginning Balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Options forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Ending Balance (in dollars per share) Beginning Balance (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Options exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Options forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate Intrinsic Value - Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life -Exercisable Restricted Stock Units (RSUs) [Member] Restricted Stock Units Restricted stock units issued and outstanding Represents the information pertaining to time based vesting of Restricted Stock Units. Restricted Stock Units, Time Based Vesting [Member] Restricted Stock Units Time Based Vesting Grantee Status [Axis] Grantee Status [Domain] Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, employees, nonemployees, and nonemployee directors. Share-Based Payment Arrangement, Employee, Non-employee, Non-employee Director [Member] Employees, non-employees and non-employee directors Director [Member] Person serving on board of non employee directors. Non Employee Director [Member] Non Employee Director Share-Based Payment Arrangement, Employee [Member] Employees Minimum [Member] Minimum Number of shares issuable for each award under share-based payment arrangement.ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Issuable for Each Award Number of shares issuable for each award Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Granted Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Number of Restricted Stock Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Ending balance Beginning balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted-Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Beginning balance Ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Forfeited Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Research and Development Expense [Member] Research and development General and Administrative Expense [Member] General and administrative Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Equity-based Compensation Share-Based Payment Arrangement, Expense Total equity-based compensation Equity-based compensation Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Total unrecognized compensation cost related to options Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average period over which the unrecognized compensation cost is expected to be recognized Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Equity Option [Member] Options issued and outstanding Warrant [Member] Warrants issued and outstanding Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net Loss per Share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Potentially dilutive common stock equivalents outstanding Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Domain] Represents the information pertaining to life science segment. Life Science Segment [Member] Life science segment Segment Reporting Information [Line Items] Segment Reporting Number of Reportable Segments Number of reportable segments Amount of income related to grants specific to company life science segment. Segment, Grant Income Grant income n/a Segment Expenses [Abstract] Less: Amount of expense for research and development incurred on clinical programs. Research and Development, Clinical Programs Clinical programs Amount of expense for research and development incurred on personnel. Research and Development, Personnel R&D Personnel costs Amount of expense for research and development incurred on preclinical programs. Research and Development, Preclinical Programs Preclinical programs Amount of expense for research and development incurred on manufacturing. Research and Development, Manufacturing Manufacturing Other Research and Development Expense Other research and development expenses Segment Reporting, Other Segment Item, Amount Other segment items Segment Reporting, Other Segment Item, Composition, Description Other segment reporting description